Guided by science.
Driven by purpose.
Our scientific advisors are leading urology experts who share our passion for improving patient outcomes in bladder cancer.
Scientific advisors
Dr Sia Daneshmand
Norris Comprehensive Cancer Center, University of Southern California, USA
Sia Daneshmand, M.D., is currently Professor of Urology and Medicine (Oncology) with Clinical Scholar designation. He serves as director of urologic oncology, as well as the urologic oncology (SUO) fellowship director at the University of Southern California (USC) in Los Angeles.
Dr Stephen B. Williams
University of Texas Medical Branch, USA
Stephen B. Williams, M.D., is the Associate Chief Medical Officer at the University of Texas Medical Branch (UTMB) Clear Lake, and the Medical Director for High-Value Care at UTMB Health System. Dr Williams is also the Robert Earl Cone Tenured Professor and Chief for the Division of Urology, Director of Urologic Oncology, and Director of Urologic Research at UTMB.
Together, we work to solve clinical challenges in superficial bladder cancer care
“Optheras ATLAS technology represent a transformative approach to managing non-invasive low-grade bladder tumors outside the OR, addressing critical unmet needs while aligning with reduction in procedural morbidity and healthcare costs.”
– Sia Daneshmand, M.D.
“Optheras introduces a more efficient, clinic-based pathway for bladder tumor care - reducing complexity while improving access, workflow, and the overall patient experience.”
– Stephen Williams, M.D.
Turning mission into momentum
With a first-in-human study to evaluate our assistive technology planned in 2026, we are raising capital for development and further clinical trials.